GC Biopharma Corp. (KOSE: A006280)
Health Care · Biotechnology · KR
₩125,800.00
+2.03% today · -3.4% 1Y
GC Biopharma Corp. (KOSE: A006280) operates in the Biotechnology industry within the Health Care sector. The company is valued at $1.07B.
Over the last twelve months the share price has lost 3.4%, trading between 105.90K and 183.80K.
Tweenvest scores GC Biopharma Corp. across four factors: quality 60/100, value 72/100, dividend 29/100. Its strongest factor is value.
A006280 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.07B
- Revenue (TTM)
- $1.27B
- P/E
- —
- EPS
- -4,372.28
- Dividend yield
- 1.19%
- Beta (5Y)
- 0.68
- 52-week high
- ₩183,800.00
- 52-week low
- ₩105,900.00
- Avg volume (3M)
- —
- Shares outstanding
- 11.41M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Vor Biopharma Inc.NasdaqGS: VOR | $1.11B | $18.26 | -2.33% |
| Ascletis Pharma Inc.SEHK: 1672 | $1.09B | HK$8.12 | -5.14% |
| Chengdu Kanghua Biological Products Co., Ltd.SZSE: 300841 | $1.09B | CN¥56.36 | +2.70% |
| L&C BIO Co.,LTDKOSDAQ: A290650 | $1.08B | ₩53,700.00 | +13.77% |
| Ingenia Therapeutics Inc.KOSDAQ: A950260 | $1.06B | ₩28,850.00 | +18.24% |
| Jiangsu Aidea Pharmaceutical Group Co., Ltd.SHSE: 688488 | $1.04B | CN¥16.63 | +4.26% |
| Beijing Strong Biotechnologies,Inc.SZSE: 300406 | $1.04B | CN¥11.94 | +1.88% |
| Immatics N.V.NasdaqCM: IMTX | $1.04B | $7.12 | -6.19% |
Figures last refreshed Oct 4, 2026.